From womb to midlife: Prenatal immune disruptions reshape memory and cognitive aging

Ava­lo Ther­a­peu­tics, a biotech work­ing on im­munol­o­gy, said its lead can­di­date failed a Phase II study test­ing the treat­ment in a spe­cif­ic type of asth­ma

Vorolanib is under clinical development by Betta Pharmaceuticals and currently in Phase II for Thymic Carcinoma.

Already established for the assessment of people with suspected acute coronary syndrome (ACS), cardiac troponin also predicted coronary events in people with symptoms suggestive of